| Literature DB >> 25768006 |
Myoungsook Lee1, Mi Kyung Kim2, Seon-Mee Kim3, Hyesoon Park4, Chang Gyu Park5, Hye Kyung Park6.
Abstract
BACKGROUND: High sodium intake is associated with the development of chronic diseases such as obesity. Although its role in obesity remains controversial, there may be a correlation between salt sensitivity and the early onset of chronic diseases in obese children.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25768006 PMCID: PMC4358955 DOI: 10.1371/journal.pone.0120111
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
General characteristics of subjects in this study.
| Characteristics | Total (n = 2163) | Boy (n = 1106) | Girl (n = 1057) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Normal | Overweight | Obestiy | p-value | Normal | Overweight | Obestiy | p-value | Normal | Overweight | Obestiy | p-value | |
|
| 1,769 | 309 | 85 | 875 | 175 | 56 | 894 | 134 | 29 | |||
|
| ||||||||||||
| 8 | 43.53 | 41.75 | 40.7 | NS | 35.71 | 3.14 | 39.54 | NS | 58.62 | 47.76 | 41.83 | NS |
| 9 | 52.94 | 55.02 | 59.13 | 58.93 | 57.71 | 60.23 | 41.38 | 51.49 | 58.05 | |||
|
| ||||||||||||
| SBP | 107.02(15.33) | 117.31(19.42) | 122.29(18.20) | <0.001 | 108.03(15.85) | 119.52(19.44) | 122.49(17.97) | <0.001 | 121.92(18.96) | 114.65(19.13) | 106.04(14.74) | <.0001 |
| DBP | 68.42(12.48) | 74.95(14.55) | 78.05(14.25) | <0.001 | 68.54(12.45) | 76.03(14.49) | 78.51(14.60) | <0.001 | 77.23(13.83) | 73.65(14.58) | 68.31(12.53) | <.0001 |
| FBS | 78.96(9.90) | 80.49(12.04) | 78.75(8.83) | NS | 79.62(10.66) | 81.39(13.28) | 78.72(8.13) | NS | 78.81(10.31) | 79.65(10.16) | 78.31(9.04) | NS |
| Insulin | 6.32(5.43) | 9.00(5.03) | 14.18(13.00) | <0.001 | 6.25(5.66) | 8.74(5.35) | 13.01(11.70) | <0.001 | 16.37(15.16) | 9.31(4.61) | 6.38(5.19) | <.0001 |
| HOMA-IR | 43.81(37.70) | 62.51(34.91) | 98.46(90.31) | <0.001 | 43.34(39.32) | 60.70(37.12) | 90.37(81.28) | <0.001 | 113.70(105.29) | 64.69(32.04) | 44.27(36.05) | 0.0024 |
| HDL | 57.09(10.17) | 52.61(9.43) | 49.57(9.12) | <0.001 | 58.22(10.17) | 53.39(9.49) | 49.93(9.58) | <0.001 | 48.82(8.21) | 51.60(9.30) | 55.97(10.08) | <.0001 |
| LDL | 100.28(26.73) | 108.61(26.42) | 111.73(27.65) | <0.001 | 98.19(25.79) | 107.17(27.62) | 111.91(24.86) | <0.001 | 111.36(33.26) | 110.46(24.77) | 102.33(27.48) | 0.0024 |
| TG | 70.80(36.10) | 94.80(54.91) | 107.56(53.23) | <0.001 | 66.15(35.53) | 86.59(51.87) | 102.74(45.43) | <0.001 | 117.58(66.51) | 105.40(57.07) | 75.39(36.08) | <.0001 |
| TG/HDL | 1.33(0.88) | 1.95(1.39) | 2.34(1.48) | <0.001 | 1.22(0.87) | 1.74(1.25) | 2.22(1.29) | <0.001 | 2.59(2.40) | 2.22(1.52) | 1.44(0.87) | <.0001 |
|
| ||||||||||||
| YES | 59.61 | 60.4 | 52.91 | NS | 68.76 | 63.06 | 63.28 | NS | 45 | 56.98 | 42.76 | NS |
| NO | 40.38 | 39.59 | 47.09 | 31.25 | 36.94 | 36.72 | 55 | 43.02 | 57.24 | |||
|
| ||||||||||||
| father | 23.7(2.6) | 24.4(2.7) | 23.7(2.5) | 0.002 | 23.8(2.7) | 24.5(2.8) | 23.9(2.6) | 0.03 | 23.6(2.5) | 24.3(2.5) | 23.3(2.4) | NS |
| mother | 21.6(2.4) | 22.02(2.5) | 22.2(2.5) | 0.03 | 21.6(2.4) | 22.0(2.5) | 21.7(2.5) | NS | 21.7(2.4) | 22.0(2.5) | 23.0(2.2) | 0.03 |
|
| ||||||||||||
| Energy | 1613.2(380.4) | 1634.7(379.8) | 1675.4(324.2) | NS | 1692.9 (387.6) | 1731.9(379.4) | 1707.5(355.1) | NS | 1539.2 (358.3) | 1518.3(347.8) | 1625.6(270.0) | NS |
| Carbohydrate | 220.9(54.3) | 219.3(50.2) | 227.4(46.4) | NS | 230.8(54.2) | 231.0(51.8) | 232.0(52.1) | NS | 211.7(52.7) | 205.3(44.6) | 220.4(35.8) | NS |
| Protein | 67.1(47.2) | 68.4(19.3) | 70.0(16.1) | NS | 69.1(17.4) | 72.4(18.8) | 71.2(14.9) | NS | 65.3(63.3) | 63.7(19.0) | 68.1(18.1) | NS |
| Fat | 53.9(17.2) | 55.6(17.4) | 55.6(15.9) | NS | 56.8(17.8) | 59.0(17.2) | 56.5(16.6) | NS | 51.3(16.2) | 51.5(16.8) | 54.1(15.0) | NS |
| Sodium | 3556.9(995.3) | 3618.9(1003.5) | 3806.2(1063.8) | NS | 3677.6(992.8) | 3862.3(1073.3) | 3728.3(927.9) | NS | 3444.8(985.4) | 3327.3(828.4) | 3926.6(1259.3) | 0.03 |
1. N(%): number(%)
2. p-value: chi-square from the 6 data in “Age” and “Physical activity”; total, boys and girls
3. Mean(SD): Mean(standard deviation) of continuous variable
4. p-value: ANOVA p-value
5.Obesity classification by BMI percentiles: obesity≥95 percentile, 85 percentile≤overweight<95percentile, normal<85 percentile for Korean children obesity criteria from Korean society of obesity.
6. Units for data; SBP & DBP:mmHg, plasma FBS, HDL, LDL & TG:mg/dL, plasma insulin: uU/ml, BMI:Kg/m2, energy & carbohydrate intakes:Kcal/day, protein & fat intakes:g/day, sodium intakes:mg/day.
Fig 1Odds ratio (OR) and 95% confidence interval (CI) for obesity risk by quintiles (Q1-Q5) of sodium intake with energy adjustment (residual-Na) were estimated in total children.
The dietary sodium intakes increases, the risk of obesity significantly increases in obesity group (black bar; P-trend < 0.05), not in overweight group (gray bar). This figure was shown by comparison with the 1st quintile vs all the others combined. Multivariate logistic regression models after adjustment for age, sex, mother’s BMI, father’s BMI, and education levels (<10 years, 10~12, 13~16 years, and >16 years) of the mother and father, dietary fat, systolic blood pressure and regular physical activity (no, yes). Means of residual-Na in each quintile for total subjects are 2287.6, 2998.9, 3496.8, 4044.9 and 5058.9 mg/day.
The distribution of genotypes for nine SNPs in our children subjects with obesity or non-obesity.
| Gene SNP | Total subjects(%) | Non-Obese Children(%) | Obese Children(%) | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Wild | Hetero | Mutant | Wild | Hetero | Mutant | Wild | Hetero | Mutant | ||
| ACE | 38.26 | 47.22 | 14.52 | 39.00 | 46.86 | 14.14 | 35.33 | 48.67 | 16.00 | NS |
| ADD1 | 19.52 | 46.17 | 34.31 | 18.58 | 46.00 | 35.42 | 23.26 | 46.84 | 29.90 | NS |
| AGT | 3.32 | 30.94 | 65.74 | 3.49 | 31.23 | 65.28 | 2.65 | 29.80 | 67.55 | NS |
| CYP11B2 | 10.17 | 42.66 | 47.18 | 9.98 | 42.81 | 47.22 | 10.93 | 42.05 | 47.02 | NS |
| GNB3 | 22.73 | 52.73 | 24.53 | 23.04 | 52.67 | 24.29 | 21.52 | 52.98 | 25.50 | NS |
| GRK4 A142V | 62.91 | 32.38 | 4.7 | 62.45 | 32.59 | 4.96 | 64.78 | 31.56 | 3.65 | NS |
| GRK4 A486V | 28.29 | 51.03 | 20.68 | 29.69 | 50.38 | 19.93 | 22.67 | 53.67 | 23.67 | 0.04 |
| NEDD4L | 15.35 | 47.44 | 37.21 | 14.70 | 47.76 | 37.54 | 17.94 | 46.18 | 35.88 | NS |
| SLC 12A3 | 83.85 | 15.49 | 0.66 | 84.60 | 14.82 | 0.58 | 80.86 | 18.15 | 0.99 | NS |
1 Abbreviation; angiotensin converted enzyme(ACE), angiotensinogen(AGT), α-addicin1(ADD1), cytochrome P450, family 11 subfamily B polypeptide 2(CYP11β-2), G-protein b3 subunit (GNB3), G protein-coupled receptor kinases type 4 (GRK4 A142V, GRK4 A486V), 11β-Hydroxysteroid Dehydrogenase type-2(HSD 11β-2), neural precursor cell-expressed developmentally downregulated 4 like(NEDD4L), solute carrier family 12(sodium/chloride transporters)-member 3(SLC 12A3) and epithelial sodium channel (ENac).
2 Significances (ANOVA p-value) on the distribution of nine SNP genotypes in obese (obesity plus overweight) or non-obese (normal) children. NS; not significant.
3 Obesity classification by BMI percentiles; obesity≥95 percentile, 85percentile≤overweight <95percentile, normal<85 percentile for Korean children obesity criteria from Korean society of obesity. In this obese group, the overweight group was included.
Fig 2Odds ratio (OR) for obesity risk by quintiles of residual-Na were estimated in boys (A) and girls (B).
X-axis means the quintiles of sodium intakes with energy adjustments, Y-axis means OR for obesity risk and bars described. OR in each genotype of gene (lighter; wild homozygote, meddle; heterozygote, darker; mutant homozygote). In case of SLC12A3, darker block was described by combination of mutant and hetero because of few mutant frequencies. Statistically significances by p<0.05(*) were shown above bars. Means of the residual-Na in each quintile for boys are 2402.9, 3122.2, 3630.7, 4202.8 and 5194.1 mg/day. Means of residual-Na in each quintile for girls are 2190.8, 2878.4, 3378.9, 3882.5 and 4889.3 mg/day. [Abbreviation: angiotensin converting enzyme; ACE, cytochrome P450, family 11 subfamily B polypeptide 2;CYP11β-2, G protein-coupled receptor kinases type 4;GRK4 A486V, solute carrier family 12(sodium/chloride transporters)-member 3;SLC12A3.]